Ostre zespoły wieńcowe - czy można zmniejszyć częstość ich występowania w Polsce?

• Autorzy: Jerzy Maciejewski , Władysław Sinkiewicz

Warianty tytułu

Acute Coronary Syndromes - Is It Possible to Decrease Their Frequency in Poland?

• Języki publikacji: PL

Abstrakty

Choroby układu krążenia, których najczęstszą postacią jest choroba wieńcowa oraz udar mózgu, stanowią najpoważniejszy problem zdrowia publicznego w Polsce. Wskaźnik śmiertelności z powodu chorób układu krążenia jest 2,5-krotnie wyższy niż w krajach Unii Europejskiej, a ta różnica utrzymuje się od lat 90. Wyniki przeprowadzonych badań klinicznych wykazały, że za wystąpienie chorób układu krążenia w ponad 90% przypadków odpowiedzialne są łatwe do zidentyfikowania czynniki ryzyka: palenie tytoniu, zaburzenia lipidowe, nadciśnienie tętnicze, cukrzyca, otyłość typu brzusznego, stres psychologiczny, nieodpowiednia dieta oraz brak aktywności fizyczne. Z danych naukowych wynika, że możliwa jest redukcja w Polsce częstości występowania ostrych incydentów wieńcowych o ok. 60% - do poziomu charakteryzującego obecnie kraje Unii Europejskiej - dzięki profilaktyce chorób układu krążenia. (abstrakt oryginalny)

EN

Cardiovascular disease, together with its main components, coronary heart disease and cerebrovascular diseases, is a leading public health problem in Poland. Mortality rate coefficient because of cardiovascular diseases in Poland is 2,5 times higher than in European Union countries and this difference maintain since 1990s. Many clinical trials revealed that nine well known and easy to identifying risk factors correspond in over 90% to the coronary artery disease and the stroke. There are: tobacco smoking, lipid disorders, arterial hypertension, diabetes, obesity of abdominal type, psychological stress, unsuitable diet as well as lack of physical activity. The available data show that the occurrence frequency of acute coronary syndromes in Poland could be decreased for about 60% - to the level currently characterizing European Union countries - by prevalence of cardiovascular diseases. (original abstract)

Słowa kluczowe

PL

Choroby; Zdrowie publiczne; Ochrona zdrowia

EN

Illness; Public health; Health care protection

• Czasopismo: Studia i Materiały Polskiego Stowarzyszenia Zarządzania Wiedzą
• Rocznik: 2010
• Tom: 38
• Strony: 130--147

Twórcy

autor

Jerzy Maciejewski

• Collegium Medicum im. L. Rydygiera w Bydgoszczy

autor

Władysław Sinkiewicz

• Collegium Medicum im. L. Rydygiera w Bydgoszczy

Bibliografia

• 1. Alberts M. J. i in., Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry, Eur Heart J, Vol 30, 2009, 2318-2326.
• 2. Arriola L. i in., Alcohol intake and the risk of coronary heart disease in the Spanish EPIC cohort study, Heart, Vol 96, 2010, 124-130.
• 3. Assmann G., Schulte H., Relation of high density lipoprotein cholesterol on triglycerides to incidence of atherosclerosis coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster Study, Am J Card, Vol 70, 1992, 733-737.
• 4. Bayturan O. i in., The metabolic syndrome, its component risk factors, and progression of atherosclerosis, Arch Intern Med, Vol 170, 2010, 478-484.
• 5. Barr D. P., Russ E. M., Eder H. A., Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions, Am J Med, Vol 11, 1951, 480-493.
• 6. Bhatt D. L. i in. (for the REACH Registry Investigators), International prevalence, recognition, and treatment of cardiovascular risk factors, JAMA, Vol 295, 2006, 180-189.
• 7. Bjerregaard L.J. i in, Fish intake and acute coronary syndrome, Eur Heart J Vol 31, 2010, 29-34.
• 8. Brunner E. J. i in., Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study, Diabetes Care, Vol 29, 2006, 26-31.
• 9. Budaj A. i in., Choroba niedokrwienna serca. W: Szczeklik A. (red.): Choroby wewnętrzne. Podręcznik multimedialny oparty na zasadach EBM. Tom I, Medycyna Praktyczna, Kraków 2005, 137-179.
• 10.Buijsse B i in., Chocolate consumption in relation to blood pressure and risk of CV disease in German adults, Eur Heart J, Vol 31, 2010, 1616-1623.
• 11.Chen J. i in., Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges, Circulation, Vol 121, 2010, 1277-1279.
• 12.Chiuve S. E. i in., Healthy Lifestyle Factors in the Primary Prevention of Coronary Heart Disease Among Men. Benefits Among Users and Nonusers of Lipid-Lowering and Antihypertensive Medications, Circulation, Vol 114, 2006, 160-167.
• 13.Cui R., Iso H., Toyoshima H., Body Mass Index and Mortality From Cardiovascular Disease Among Japanese Men and Women, Stroke, Vol 36, 2005, 1377-1382.
• 14.Davis R. M., Volsett S. E., Smokers often die prematurely: study, Ann Int Med, Vol 21, 2006, 299-301.
• 15.Dawber T. R. i in, Some factors associated with the development of coronary heart disease; six years' follow-up experience in the Framingham Study, Am J Public Health, Vol 49, 1959, 1349-1356.
• 16.Dekker J. M., Girman C., Rhodes T., Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study, Circulation, Vol 112, 2005, 666-673.
• 17.Dresler C. M. i in, Reversal of risk upon quitting smoking, Lancet, Vol 368, 2006, 348-349.
• 18.Drexel H., Reducing risk by raising HDL-cholesterol: the evidence, Eur Heart J, Vol 8 Suppl, 2006, 23-29.
• 19. Eastman R. C. i in., Implications of the Diabetes Control and Complications Trial, Diabetes Care, Vol 24, 2001, 28-32.
• 20. Ellison R. C. i in., Lifestyle determinants of high-density lipoprotein cholesterol: The National Heart, Lung and Blood Institute Family Heart Study, Am Heart J, Vol 147, 2004, 529-535.
• 21. Elmer P. J., Obarzanek E., Vollmer W. M. (PREMIER Collaborative Research Group), Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial, Ann Intern Med, Vol 144, 2006, 485-495.
• 22. Estruch R. i in. (PREDIMED Study Investigators), Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors. A Randomized Trial, Ann Intern Med, Vol 145, 2006, 1-11.
• 23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP), JAMA, Vol 285, 2001, 2486-2497.
• 24. Field A. E. i in., Impact of overweight on the risk of developing common chronic diseases during a 10-year period, Arch Intern Med, Vol 161, 2001, 1581-1586.
• 25. Forster D. P., Jozan P., Health in Eastern Europe, Lancet, Vol 335, 1990, 458-460.
• 26. Fowkes F. G. i in., Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study, Eur Heart J, Vol 27, 2006, 1861-1867.
• 27. Fryar C. D. i in., Hypertension, high serum total cholesterol, and diabetes: Racial and ethnic prevalence differences in U.S. adults, 1999-2006. NCHS, National Center for Health Statistics no 36, Hyattsville, 2010
• 28.Gotto A. M., Improving Lipid Goal Attainment. Is It Enough?, Circulation Vol 120, 2009, 3-5.
• 29.Gordon-Larsen P i in., Active commuting and cardiovascular disease risk, Arch Intern Med, Vol 169, 2009, 1216-1223.
• 30.Halton T. L. i in., Low-Carbohydrate-Diet Score and the Risk of Coronary Heart Disease in Women, NEJM, Vol 355, 2006, 1991-2002.
• 31.Han T. S., Waist circumcerence action levels in the identification of cardiovascular risk factors: prevelance study in random sample, Br Med J, Vol 311, 1995, 1401-1405.
• 32.Harris M. I., Impaired glucose tolerance: prevalance and conversion to NIDDM, Diabet Med, Vol 13, 1996, 9-11.
• 33.Huxley R. i in., Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus. A Systematic Review With Meta-analysis, Arch Intern Med, Vol 169, 2009, 2053-2063.
• 34. Iestra J. A., Kromhout D., van der Schouw Y.T., Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients, Circulation, Vol 112, 2005, 924-934.
• 35. Iso H. i in., Intake of Fish and n3 Fatty Acids and Risk of Coronary Heart Disease Among Japanese. Circulation, Vol 113, 2006, 195-202.
• 36. Isomaa B. i in., Cardiovascular morbidity and mortality associated with the metabolit syndrome. Diabetes Care, Vol 24, 2001, 683-689.
• 37.Kannel W. D. i in., Concept and usefulness of cardiovascular risk profiles. Am Heart J, Vol 148, 2004, 16-26.
• 38.Kuk J. I., Ardern C., Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care, Vol 32, 2009, 2297-2299.
• 39.Klein S. i in., Clinical implications of obesity with specific focus on cardiovascular disease. A statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism, Circulation, Vol 110, 2004, 2952-2967.
• 40.Koek H. L. i in., Decline in incidence of hospitalisation for acute myocardial infarction in the Netherlands from 1995 to 2000, Heart, Vol 92, 2006, 162-165,
• 41.Kotseva K. i in. (EUROASPIRE Study Group), Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet, Vol 373, 2009, 929-940.
• 42. Lee C. D. i in., Combined effects of cardiorespiratory fitness, not smoking, and normal waist girth on morbidity and mortality in men, Arch Intern Med, Vol 169, 2009, 2096-2101.
• 43. Levantesi G. i in., Metabolic syndrome and risk of cardiovascular events after myocardial infarction, J Am Coll Cardiol, Vol 46, 2005, 277-283.
• 44. Levit K. i in., HCUP Facts and Figures 2007: Statistics on hospital-based care in the United States, Agency for Healthcare Research and Quality, Rockville, 2009.
• 45. Lewington S. i in., Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, Vol 360, 2002, 1903-1913.
• 46. Lichtenstein A. H. i in., Diet and lifestyle recommendations, revision 2006. A scientific statement from the American Heart Association Nutrition Committee. Circulation Vol 114, 2006, 82-96.
• 47. Lightwood J. M., Glantz S. A., Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation, Vol 120, 2009, 1373-1379.
• 48.Maraldi C., Volpato S., Kritchevsky S. B., Impact of Inflammation on the Relationship Among Alcohol Consumption, Mortality, and Cardiac Events, Arch Intern Med, Vol 166, 2006, 1490- 1497.
• 49.Marso S. P., Ellis S. G., Choroba wieńcowa a cukrzyca, W: Braunwald E., Postępy w kardiologii Harrisona, Wydawnictwo Czelej, Lublin, 2005, 176-182.
• 50.Mohan S. i in., Effective population-wide public health interventions to promote sodium reduction. CMAJ, Vol 181, 2009, 605-609.
• 51.Müller-Nordhorn J. i in., An update on regional variation in cardiovascular mortality within Europe, Eur Heart J, Vol 29, 2008, 1316-1326.
• 52.Neaton J. D. i in. (for the Multiple Risk Factor Intervention Trial Research Group), Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease, Arch Intern Med, Vol 152, 1992, 56-64.
• 53.Nieves D. J., Cnop M., Retzlaff B., The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes, Vol 52, 2003, 172-179.
• 54.O'Flaherty M. i in., Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart, Vol 94, 2008, 178-181.
• 55.Onat A., Sansoy V., Yildirim B., Which fasting triglyceride levels best reflect coronary risk? Evidence from the Turkish Adult Risk Factor Study, Clin Cardiol, vol 24, 2001, 9-14.
• 56. Patel N. B., Balady G.J., The Rewards of Good Behavior, Circulation, Vol 121, 2010, 733- 735.
• 57. Poirier P., Cardiologists and abdominal obesity: lost in translation? Heart, Vol 95, 2009, 1033-1035.
• 58. Prescott E. i in., Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study, J Epidemio Comm, Health, Vol 56, 2002, 702-706.
• 59. Prusiński A. i in., Czynniki ryzyka i profilaktyka udarów niedokrwiennych mózgu, W: Niedokrwienne udary mózgu, alfa-medica Press, Bielsko-Biała, 1999, 31-59.
• 60.Rigotti N. A., Helping smokers with cardiac disease to abstain from tobacco after a stay in hospital, CMAJ, Vol 180, 2009; 1283-1284.
• 61.Rubins H. B. i in., Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT), Arch Intern Med, Vol 162, 2002, 2597-2604.
• 62.Rywik S. i in., The changes in risk factors levels after two years of implementation of the coronary diseases prevention in Poland. I. The dynamics of changes in total population, Przegl Lek, Vol 38, 1981, 769-770.
• 63. Sabaté J. i in., Nut consumption and blood lipid levels, Arch Intern Med, Vol 170, 2010, 821- 827.
• 64. Sans S., Kesteloot H., Kromhout D., The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe, Eur Heart J, Vol 18, 1997, 1231-1248.
• 65. Sattelmair J. i in., Physical Activity and Risk of Stroke in Women. Stroke, Vol 41, 2010, 1243- 1250.
• 66. Schroeder S. A., Public Smoking Bans Are Good for the Heart, J Am Coll Cardiol, Vol 54, 2009, 1256-1257.
• 67. Sever P. S. i in., Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo- Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet, Vol 361, 2003, 1149-1158.
• 68. Simons L. A., Sullivan D. R., Lipid-modyfying drugs, M J A, Vol 182, 2005, 286-289.
• 69. Stewart S. T., Cutler D. M., Rosen A. B., Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med, Vol 361, 2009, 2252-2260.
• 70. Stratton I. M. i in., Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, Br Med J, Vol 321, 2000, 405-412.
• 71. St-Pierre A. C. i in., Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. C M A J, Vol 172, 2005, 1301-1305.
• 72. The DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe), Consequences of the new diagnostic criteria for diabetes in older men and women, Diabetes Care, Vol 22, 1999, 1667-1671.
• 73. Tu J. V., Nardi L., Fang J., National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004, CMAJ, Vol 180, 2009, 118-25.
• 74.WHO Regional Office for Europe, The European Health Report 2002, WHO Regional Publications, European Series, Copenhagen, No. 97.
• 75.Wijeysundera H. C. i in., Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, JAMA, Vol 303, 2010, 1841-1847.
• 76.Vasan R. S. i in., Impact of High-Normal Blood Pressure on the Risk of Cardiovascular disease. Framingham Heart Study. NEJM, Vol 345, 2001, 1291-1297.
• 77.Vriz O. i in., Smoking is associated with higher cardiovascular risk in young women than in men: the Tecumseh Blood Pressure Study, J Hypertens, Vol 15, 1997, 127-134.
• 78.Widimsky P. i in., Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries, Eur Heart J, Vol 31, 2010, 943-957.
• 79.Williamson J., Pahor M., Evidence regarding the benefits of physical exercise, Arch Intern Med, Vol 170, 2010, 124-125.
• 80.Wojtyniak B., Goryński P., Seroka W., Stan zdrowia ludności Polski na podstawie danych o umieralności. Przedwczesna umieralność w Polsce na tle sytuacji w Unii Europejskiej, W: Wojtyniak B., Goryński P. (red.), Sytuacja zdrowotna ludności Polski. Państwowy Zakład Higieny - Zakład Statystyki Medycznej, Warszawa 2003, 47-55.
• 81.Wojtyniak B., Goryński P., Seroka W., Stan zdrowia ludności Polski na podstawie danych o umieralności. Umieralność z powodu chorób układu krążenia, W: Wojtyniak B., Goryński P. (red.), Sytuacja zdrowotna ludności Polski, Państwowy Zakład Higieny - Zakład Statystyki Medycznej, Warszawa 2003, 21-30.
• 82.Yeh C. H. i in., Smoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus, Ann Intern Med, Vol 152, 2010, 10-17.
• 83.Yusuf S. i in. (INTERHEART Study Investigators), Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study, Lancet, Vol 366, 2005, 1640-1649.